相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
Robert L. Gottlieb et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
D. M. Weinreich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
(A Little) Clarity on Convalescent Plasma for Covid-19
Louis M. Katz
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
V. A. Simonovich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19 A Systematic Review and Meta-analysis
Perrine Janiaud et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity
Benjamin Trinite et al.
SCIENTIFIC REPORTS (2021)
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial
Maria Elvira Balcells et al.
PLOS MEDICINE (2021)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Peter W. Horby et al.
LANCET (2021)
Effect of Methylene Blue Pathogen Inactivation on the Integrity of Immunoglobulin M and G
Johannes Raster et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2021)
Impact of pathogen reduction methods on immunological properties of the COVID-19 convalescent plasma
Alexander I. Kostin et al.
VOX SANGUINIS (2021)
Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease
Manaf AlQahtani et al.
SCIENTIFIC REPORTS (2021)
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Philippe Begin et al.
NATURE MEDICINE (2021)
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
M. Dougan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Early Convalescent Plasma for High-Risk Outpatients with Covid-19
Frederick K. Korley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals
Benjamin Trinite et al.
VIRUSES-BASEL (2021)
COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors
Daniele Focosi et al.
VIRUSES-BASEL (2021)
Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
Arvind Gharbharan et al.
NATURE COMMUNICATIONS (2021)
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
Katie L. Kunze et al.
NATURE COMMUNICATIONS (2021)
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia
Cristina Avendano-Sola et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
A minimal common outcome measure set for COVID-19 clinical research
J. C. Marshall et al.
LANCET INFECTIOUS DISEASES (2020)
The role of biomarkers in diagnosis of COVID-19-A systematic review
Muhammed Kermali et al.
LIFE SCIENCES (2020)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)